Showing results (1371-1380 of 1,479) with videos related to

Sort By:
Pageof 148
Blood|April 5, 2013
A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)Daniel H Wiseman, Alison May, Stephen Jolles, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2023
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer typesJammbe Z Musoro, Corneel Coens, Mirjam A G Sprangers, et al.
Investigative Ophthalmology & Visual Science|March 20, 2012
Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR)James A Poulter, Alice E Davidson, Manir Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsChantal Quinten, Corneel Coens, Irina Ghislain, et al.
Hepatology International|April 6, 2021
Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and KuwaitFaisal M Sanai, Abdullah Al Khathlan, Ahmad Al Fadhli, et al.
European Urology|October 5, 2014
Focal therapy: patients, interventions, and outcomes--a report from a consensus meetingIan A Donaldson, Roberto Alonzi, Dean Barratt, et al.
Targeted Oncology|November 9, 2020
Developing Symptom Lists for People with Cancer Treated with Targeted TherapiesSamantha C Sodergren, Sally J Wheelwright, Deborah Fitzsimmons, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesisSiddharth Banka, Stuart A Cain, Sabrya Carim, et al.
The Lancet. Oncology|February 7, 2017
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trialCorneel Coens, Stefan Suciu, Vanna Chiarion-Sileni, et al.
Cancer Treatment Reports|February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomasJ A Gottlieb, R S Benjamin, L H Baker, et al.
Pageof 148